Molecular imaging can accelerate anti-angiogenic drug development and testing.
Iagaru
Andrei
A
Stanford University School of Medicine, Stanford, CA, USA.
Chen
Xiaoyuan
X
Gambhir
Sanjiv Sam
SS
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D015195:Drug Design; D006801:Humans; D008279:Magnetic Resonance Imaging; D009369:Neoplasms; D049268:Positron-Emission Tomography; D015899:Tomography, Emission-Computed, Single-Photon
D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents